Phase I study of PM534 to patients with advanced solid tumors

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.

Registry ID

ISRCTN97337444

Source registry

ISRCTN

Status

Recruiting

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

PharmaMar (Spain)

Enrollment

15

Start date

2026-04-10

Completion date

2028-08-08

Last update

2026-08-17

Conditions

• Other

Summary

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.

Detailed description

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.

Interventions

• DRUG: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.

Inclusion criteria

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.

Exclusion criteria

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.

Locations

• , , United Kingdom
• , , England
• , , Spain

Related clinical trials

• Helping young people to adapt their internet use and promote mental well-being in a rapidly changing world
• Testing a job crafting intervention to help make work more manageable, engaging and enjoyable for UK workers
• Understanding the impact of resistant bugs on deaths in England
• Helping local authorities to help parents: the BeST Engage Project
• Copen-SCALE: Scaling up an effective intervention to childcare institutions in Copenhagen
• Deferred registration: Quotient Sciences code: QSC303996

View on source registry